Published in Rev Gastroenterol Peru on July 17, 2009
Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China. Saudi J Gastroenterol (2017) 0.77
In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori. Indian J Hum Genet (2013) 0.76
[Helicobacter pylori: 25 years after]. Rev Gastroenterol Peru (2009) 0.75
[Helicobacter pylori: 25 years after]. Rev Gastroenterol Peru (2009) 0.75
Local Immune Response in Helicobacter pylori Infection. Medicine (Baltimore) (2016) 0.75
[Latin American contribution to the study of Helicobacter pylori]. Acta Gastroenterol Latinoam (2009) 1.40
[Helicobacter pylori and gastric cancer]. Rev Gastroenterol Peru (2008) 0.80